• Home Interface Controller

    Sunstein has prosecuted a portfolio of patents devoted to the emerging industry of interactive television. Our client ICTV has developed technology that enables cable television subscribers to receive video programming that allows them to interact with their television to play games, videos and music on demand; browse news, sports and weather; and view targeted interactive advertising.

  • Molecular Diagnostic System

    We obtained the patent for Source Precision Medicine’s molecular diagnostic system that measures cellular gene expression with significant precision to assess and track an individual’s current health, disease status and response to drug therapy, potentially a foundation for the future practice of medicine.

  • Acoustic Analysis of Bone

    Patents prosecuted by Sunstein protect technologies, including transient signal processing techniques developed by the Metra Biosystems division of Quidel Corp., that are used in compact ultrasonic devices to measure bone density as an aid in detecting osteoporosis.

  • Magnetization Technology

    Sunstein successfully negotiated a multi-million dollar settlement on behalf of Comair Rotron, following a jury verdict that our client’s patent was infringed. The patent was directed to important magnetization technology for brushless DC electric motors.

Patents. Juries. Success.

Abbott Laboratories v Syntron Bioresearch, Inc.

In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.

Gates Formed-Fibre Products, Inc. v. Delaware Valley Corp.

By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting.

Our successful advocacy extends to patent reexaminations and interferences.

Winning at IPRs

Samsung Electronics Co., Ltd. v. Arendi S.A.R.L.

Samsung attacked our client’s patent in the Patent Trial and Appeal Board (PTAB) on grounds of obviousness. We persuaded the PTAB that an element of the claims was not disclosed by the cited references and thus prevented the inter partes review from even being instituted.

Spotlight on Patents

diagram1 For our client Dr. Leslie Stern of Fall River, Massachusetts, we recently obtained US Patent No. 8,460,310, describing a medical device for use in minimally invasive spine surgery.

In the News

Our Latest Thinking

  • Trademark litigants might change their tactics now that the Supreme Court has held that rulings of the Trademark Trial and Appeals Board may preclude subsequent litigation of the same issue in federal court.

  • US patent owners can enforce their rights against infringers who act mostly overseas, but only to the extent of a nexus with the US.

  • For US inventors, it’s easy to get broader and stronger protection for industrial designs, now that the US has joined an international treaty.

  • Recent decisions put added pressure on software developers to recite a sufficiently definite structure to support means-plus-function patent claims.

  • The PTAB has typically construed patent claims more broadly than do the federal trial courts, which can expose patents to invalidation. The Federal Circuit has eased that concern by shrinking the difference between the administrative and judicial standards.

  • The Federal Circuit has brought order to the process of navigating patent challenges and appeals through the PTAB and federal courts.


Free Subscription

See more in Publications/News